ARCHIVES

Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial?

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award

June 10, 1988

Canadian NCI Plans Review Of National Breast Screening Study

February 24, 1995

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983